Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease

NCT06249932 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure with Reduced Ejection Fraction
End Stage Renal Disease on Dialysis

Interventions

DRUG: Empagliflozin 25 MG
DRUG: Placebo

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]